ADCT
insider transactionsADC Therapeutics SA — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
+7.7M
7.7M buy · 0 sell
Net value · 365d
$30.0M
$30.0M in · $0 out
Sentiment · 365d
Net buying
100% buying · 0% selling
Open-market trades · 365d
2
7.7M buy · 0 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Other·F
Chief Accounting Officer
$21.7K
5.4K sh · $3.99
Own -4%
-
Grant·A
Chief Accounting Officer
$251.0K
62.9K sh · $3.99
Own +89%
-
Other·F
Carmona Jose KEY
Chief Financial Officer
$103.3K
25.9K sh · $3.99
Own -3%
-
Grant·A
Carmona Jose KEY
Chief Financial Officer
$1.1M
271.6K sh · $3.99
Own +56%
-
Other·F
Chief Legal Officer
$132.8K
33.3K sh · $3.99
Own -5%
-
Grant·A
Chief Legal Officer
$1.2M
294.8K sh · $3.99
Own +82%
-
Grant·A
Chief Medical Officer
$1.1M
285.2K sh · $3.99
Own +68%
-
Other·F
Chief Medical Officer
$98.2K
24.6K sh · $3.99
Own -3%
-
Grant·A
MALLIK AMEET KEY
Chief Executive Officer
$3.6M
900.0K sh · $3.99
Own +138%
-
Other·F
MALLIK AMEET KEY
Chief Executive Officer
$411.9K
103.2K sh · $3.99
Own -7%
-
Other·F
MALLIK AMEET KEY
Chief Executive Officer
$767.1K
233.1K sh · $3.29
Own -15%
-
Other·F
Chief Accounting Officer
$23.5K
7.1K sh · $3.29
Own -9%
-
Other·F
Carmona Jose KEY
Chief Financial Officer
$175.1K
53.2K sh · $3.29
Own -10%
-
Other·F
Chief Medical Officer
$135.1K
41.1K sh · $3.29
Own -9%
-
Other·F
Chief Legal Officer
$162.9K
49.5K sh · $3.29
Own -12%
-
Buy·P
TenPercentOwner
$15.0M
3.8M sh · $3.90
Own New
-
Buy·P
TenPercentOwner
$15.0M
3.8M sh · $3.90
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Feb 13, 2026 | Kallebo Lisa Michelle | Other F | 5.4K | $21.7K |
| Feb 13, 2026 | Kallebo Lisa Michelle | Grant A | 62.9K | $251.0K |
| Feb 13, 2026 | Carmona Jose KEY | Other F | 25.9K | $103.3K |
| Feb 13, 2026 | Carmona Jose KEY | Grant A | 271.6K | $1.1M |
| Feb 13, 2026 | GRAHAM PETER J | Other F | 33.3K | $132.8K |
| Feb 13, 2026 | GRAHAM PETER J | Grant A | 294.8K | $1.2M |
| Feb 13, 2026 | Zaki Mohamed | Grant A | 285.2K | $1.1M |
| Feb 13, 2026 | Zaki Mohamed | Other F | 24.6K | $98.2K |
| Feb 13, 2026 | MALLIK AMEET KEY | Grant A | 900.0K | $3.6M |
| Feb 13, 2026 | MALLIK AMEET KEY | Other F | 103.2K | $411.9K |
| Dec 6, 2025 | MALLIK AMEET KEY | Other F | 233.1K | $767.1K |
| Dec 6, 2025 | Kallebo Lisa Michelle | Other F | 7.1K | $23.5K |
| Dec 6, 2025 | Carmona Jose KEY | Other F | 53.2K | $175.1K |
| Dec 6, 2025 | Zaki Mohamed | Other F | 41.1K | $135.1K |
| Dec 6, 2025 | GRAHAM PETER J | Other F | 49.5K | $162.9K |
| Oct 27, 2025 | Green Jeremy | Buy P | 3.8M | $15.0M |
| Oct 27, 2025 | Green Jeremy | Buy P | 3.8M | $15.0M |
About ADCT insider trading
This page tracks insider transactions for ADC Therapeutics SA (ADCT) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.